Company Filing History:
Years Active: 2020-2022
Title: Innovations by Hans Zahn in Genomic Analysis
Introduction
Hans Zahn is a notable inventor based in Munich, Germany. He has made significant contributions to the field of genomic analysis, particularly in methods for assessing genomic variation within cells. With a total of 3 patents, his work has implications for cancer research and genetic diagnosis.
Latest Patents
Zahn's latest patents focus on methods, devices, and systems for analyzing precious samples of cells, including single cells. These innovations are designed to assess genomic heterogeneity, which is a central feature of many cancers. His inventions play a critical role in understanding disease initiation, progression, and response to treatment. Additionally, these methods are utilized for analyzing embryonic biopsies for preimplantation genetic diagnosis (PGD). Notably, his devices and systems allow for the construction of genomic and RNA-seq libraries without a pre-amplification step.
Career Highlights
Hans Zahn is affiliated with the University of British Columbia, where he continues to advance research in genomic analysis. His work has garnered attention for its potential to revolutionize how genomic data is interpreted in clinical settings.
Collaborations
Zahn collaborates with esteemed colleagues, including Carl Lars Genghis Hansen and Jens Huft. Their combined expertise enhances the impact of their research in the field of genomics.
Conclusion
Hans Zahn's innovative contributions to genomic analysis demonstrate the importance of his work in advancing medical research and improving diagnostic techniques. His patents reflect a commitment to understanding complex biological systems and their implications for health.